Abbreviation s used: APB, 2-amino-4-phosphonobutyric acid; APV, 2-amino-5-phosphonovaleric acid; ERG, electroretino gram; NMDA, N-methyl-D-aspartate; TTX, tetrodotoxin.
Summary: Previous studies have shown that most of the energy consumption of eNS tissue is used for processes that sub serve signaling functions of the cells. Since these function-related processes are probably not essential to cell viability, blocking them reversibly with a combina tion of pharmacologic agents should protect cells from a reduction in energy metabolism. Preliminary experiments to test this hypothesis were performed on isolated rabbit retinas. They were maintained in a newly devised cham ber that permitted continuous monitoring of electrophys iological function for �8 h. Ischemia was simulated by a 6-fold reduction in both O 2 and glucose. This caused a rapid (tl/2 75 s) and complete loss of the light-evoked re-Because the largest net fluxes by far from blood to cells involve substances required for energy me tabolism, the initial effect of a reduction in blood flow is a reduction in the cells' energy metabolism. Ischemia occurs when the energy the cells can gen erate falls appreciably below the energy they re quire, and the myriad adverse effects of ischemia are a consequence of this energy imbalance. This is, of course, not a new concept. The relation between physiologic activity and ischemia has long been rec ognized in the case of skeletal muscle (intermittent claudication) and cardiac muscle (effort-induced an gina). Efforts have been made previously to protect brain from infarction by slowing its activity, usually using a single pharmacologic agent (see, e. g. , As-sponse in the optic nerve. Untreated retinas showed full recovery after Y2 h of deprivation, but only 50% recovery after 1 h and little or no recovery after 2 or 3 h. Retinas exposed during 3 h of deprivation to a combination of six agents that abolished electrophysiologic function and reduced glucose utilization [tetrodotoxin (TTX), 2-amino-4-phosphonobutyric acid (APB), 2-amino-5phosphonovaleric acid (APV), amiloride, Mg 2 +, and Li + 1 showed full recovery. We conclude that reducing energy requirements by blocking functional processes can prevent ischemic damage. Key Words: Retina Energy metabolism-Stroke-Protection-Hypoxia Hypoglycemia. trup, 1982; Hochachka, 1986; Wright and Ames, 1964; Michenfelder and Theye, 1973; Chih et aI., 1989) .
Neurons utilize many different energy-requiring functional processes (e.g., gating different ion fluxes; activation of second-messenger systems), most of which probably continue even after isch emic changes have interrupted normal function. Be cause blockade of a single process cannot be ex pected to cause a large fractional reduction in total energy requirements, a substantial protection against ischemia by this approach will require the simultaneous use of a number of agents, each of which reversibly interrupts one or more function related processes without interfering with the basic, vegetative metabolic processes that are required for viability.
Data currently available indicate that a relatively small amount of the energy metabolism of neurons is required to maintain their vegetative metabolism and that the vast majority of their energy is used to support their functional activity (e.g. , . If a significant portion of these energy-requiring function-related processes can be blocked, it should be possible to protect neurons during a period in which their capacity to generate energy is markedly reduced.
We report here a preliminary test of this hypoth esis. We used a combination of six agents: tetrodo toxin (TTX), 2-amino-4-phosphonobutyric acid (APB), 2-amino-5-phosphonovaleric acid (APV), amiloride, Mg 2 +, and Li+. They were selected on the basis of previous studies (Ames and Zager, 1987; Zager and Ames, 1988) for their ability to re versibly reduce the functional activity and energy requirements of neurons, but were not selected with particular regard for possible clinical usefulness. The experiments were performed on isolated rab bit retina, and we used recovery of the optic nerve response to light as a measure of cell survival fol lowing an ischemic challenge. The three layers of neurons in retina are incorporated into rather com plex circuits, and preservation of the optic nerve responses to both ON and OFF of light provides evidence that the functional integrity of most of the retinal neurons has been retained. Having the tissue in vitro permitted prompt introduction (and re moval) of known concentrations of test agents, without uncertainties about binding to serum pro teins or gradients across the blood-brain barrier, and it eliminated the possibility that the action of the drugs was on the vasculature rather than on the neurons themselves. The ischemic challenge was designed to simulate stroke in vivo and consisted of a 6-fold reduction in both O 2 and glucose. The re covery of retinas exposed to the drug combination during the deprivation was compared with the re covery of untreated controls.
METHODS

Tissue preparation
New Zealand White rabbits weighing � 3 kg were dark adapted for 1 h and anesthetized with an intramuscular injection of 10-12 ml of a 1: 1 mixture of ketamine (50 mg ml-I) and xylazine (20 mg ml-I). An eye was removed with � 1 cm of attached optic nerve, and the retina and nerve were separated from the surrounding tissues under dim red light. The animals were killed while still anesthe tized. The retinas were maintained in darkness in a me dium that simulated CSF with respect to electrolytes and 38 organic constituents (Ames Medium; Sigma, St. Louis, MO, U.S.A.). A detailed account of these procedures has been published (Ames and Nesbett, 1981) .
Incubation chamber
The chamber, shown in cross-section in Fig. 1 , con tained 28 ml of medium that was distributed in a torus-like shape by the mandrel over which the retina was deployed and by the "upper element" into which the optic nerve had been drawn. A vigorous movement of the medium over the choroidal surface of the retina was generated by the bubbling of the equilibrating gas that was delivered through no. 28 gauge stainless steel needles into six 4-mm trical recordings. The components of the chamber were ma chined from lucite and included a mandrel below (retained by an O-ring) and an "upper element" which provided a "mannitol gap" to enhance the nerve recordings. The optic nerve was drawn into the "upper element" in the dissection dish. The nerve with suspended retina, was then transferred to the medium-filled chamber, and the "upper element" was immobilized where it passed through a circular opening in the chamber lid (which had been hemisected to make the assemblage easier). A thermistor probe is shown at upper left, drain used for changing medium at lower right. See text for further details.
(diameter) channels drilled in the chamber wall. The total gas flow into the chamber was monitored by flowmeter (Cole Palmer) and maintained at 165 ± 3 ml min -I. The retina was isolated at 30°C. Room temperature was then increased to 37°C, and medium temperature was main tained at 37 ± O.4°C by circulating water from a constant temperature circulator (Lauda) through four coils of sili cone tubing wrapped around the chamber (not shown).
Electrical recording
The "upper element" of the chamber contained a cen tral channel 3 mm in diameter. A thin (3 mil) silicone rubber membrane with a small (0.8 mm) central hole was sealed to its lower end and a second, similar membrane with-hole was positioned 4 mm above the first. Access to the space between the membranes was provided by small vertical channels so that the segment of nerve traversing this space could be perfused with an isotonic mannitol solution introduced by needle into one of the channels and aspirated by needle from the other. Another, similar pair of small side-channels (not visible in the plane of section of Fig. 1 ) provided access to the central channel above the upper membrane and permitted perfusion of an electrolyte solution (the medium) between the cut end of the nerve and the electrode above. The nerve was drawn into the "upper element" using a 7-0 prolene suture that had been led through the holes in the silicone membranes and up the central channel of the upper element. Action potentials in the nerve were recorded between the (refer ence) electrode in the "upper element" and an (active) electrode suspended in the medium (Fig. 1, right) . Re placing incubation medium with isotonic mannitol in the space between the two membranes resulted in a 2-to 3-fold increase in the action potentials recorded from the nerve. The mandrel contained a medium-filled channel to connect the vitreous surface of the retina with an elec trode below, which was used, together with the electrode in the chamber, to record the electroretinogram (ERG). The electrodes were coils of chlorided Ag wire (34 gauge) in glass tubing containing a solution of half-saturated KCl in agar. They were stored (with the wires short-circuited) in the electrolyte solution containing I mM EDT A to re duce the concentrations of toxic divalent cations and Ag +. Signals were amplified and recorded (Gould) using a band pass of 0.05-100 Hz. Light flashes of I s were used to permit the ON of the nerve response to be easily dis tinguished from the OFF. An intensity that elicited a max imum b wave in the ERG was selected at the beginning of an experiment and used throughout an experimental day for eliciting the nerve responses. A much higher intensity was used infrequently to assess changes in the PIn of the ERG. On the basis of previous studies, we estimate that the lower intensity caused I or 2 photoisomerizations per rod outer segment per second (Rh * sec -1) and that the higher intensity caused> 100 Rh* sec -1.
Selection of ischemic conditions
Our objective was to simulate a stroke as seen in vivo, in which there is residual flow to the tissue at risk via collaterals. In a number of studies in which regional blood flow has been estimated following occlusion of the middle cerebral artery in cats, subhuman primates, and patients, infarction was usually observed when flow fell to I/4 or less of control levels for 2 h or longer (Hossmann and Schuier, 1980; Shimada et aI., 1989; Symon et aI., 1974; Morawetz et aI., 1979; Powers et aI., 1985) . Guided by these findings, we used for our ischemic challenge a 6-fold reduction of both O 2 and glucose (0 2 from 95 to 15% and glucose from 6 to I mM) for I/2, I, 2, or 3 h.
Selection of protective agents
The agents and the concentrations at which they were used were selected on the basis of previous tests of 75 agents administered alone (Ames and Zager, 1987; Zager and Ames, 1988; Ames et aI., 1992; . The following six agents were selected because they had been found to act reversibly to cause relatively large re ductions in energy consumption and because they were expected to act at different sites. Tetrodotoxin (0. 1 J.LM) was used to block the voltage-sensitive Na + channel. DL APB (20 J.LM) was used as an inhibitory agonist and DL APV (l mM) was used as an excitatory antagonist at dif ferent types of glutamate receptors (e.g., Massey, 1990) . Amiloride (1 mM) was used to block the low threshold Ca 2 + channel and to interrupt Na + -H + and Na + _Ca 2 + exchange (Tang et aI., 1988; Foster et aI., 1986; Schellen berg et aI., 1983) . Mg 2 + (10 mM) was used to block trans mitter release, to block Ca 2 + movement through N-meth yl-D-aspartate (NMDA) receptors, and to act as a Ca 2 + competitor at other sites. Li + (10 mM) was expected to act by interrupting the inositol triphosphate cycle (Ber ridge, 1984) and perhaps by substitution for intracellular Na + in the most active cells. Na + was reduced to com pensate for the cation equivalents represented by the ad dition of Li + and the increase in Mg 2 + .
Protocol
Light-evoked responses were recorded under control conditions; the retinas were subjected to the reduction in O 2 and glucose with or without protective agents; and they were then returned to control conditions for 4 h, with the light-evoked responses recorded about every 1f2 h to assess recovery. In some experiments, the glucose con tent of the deprivation medium was measured (using the glucose hexokinase method) before, and again 2 or 3 h after, exposure to the retina.
RESULTS
Light-evoked action potentials under control conditions; calculation of the response to test conditi<;ms
The I-s flashes elicited sharply-peaked com pound action potentials in the optic nerve in re sponse to both ON and OFF of the light (see upper most recordings in Fig. 2) . The ON response aver aged 245 ± 115 I-l V (SD; n = 13), and the OFF response averaged 190 ± 68 I-l V. The responses of a given retina remained quite constant under control conditions. There was more variability between ret inas, probably attributable to differences in the way they were dissected and prepared for recording. In the data to be presented, each retina was used as its own control.
Previously published studies have shown that the circuits responsible for the ON and OFF responses are quite distinct (e .g., Schiller et al., 1986) ; so they can serve as separate indicators of effective neuro transmission through the neural retina. Under the conditions of our experiments, the changes ob served in the OFF response paralleled closely the changes in the ON response (Fig. 2) . To assess changes in retinal function under experimental con ditions ( Figs. 3 and 4) , we averaged the changes in the ON and OFF responses when each had been expressed as a percentage of the response under control conditions.
Response to the ischemic insult in the absence of protective agents
When O 2 and glucose were both reduced by a factor of 6, the action potentials fell to Y2 of the control value in about 75 s, and to 0 in 4-6 min (Fig.  3, left) . Because changing the medium interfered with recording, it was not possible to document the response to the first seconds of deprivation or to evaluate the latency of the response (if any). Re covery varied as a function of the length of the de- PfIOlEilON   FIG. 2. Light-evoked compound action potentials were recorded from the optic nerves of retinas subjected to varying periods of "ischemia," with and without protection. The traces show the response to both ON and OFF of a 1-s period of illumination (in dicated by the bar beneath the recordings). The uppermost trace in each set of three was recorded under control condi tions; the middle trace was re corded at the end of the period of "ischemia"; and the lower most trace was recorded after the retina had achieved ma),:· mal recovery, usually within 4 '/2 h after return to control condi tions. Ischemia was simulated by subjecting the retina to a 6-fold reduction in both glucose (from 6 to 1 mm) and O 2 (from 95 to 15%). Protection was pro vided to the four retinas shown in the lower half of the figure by a combination of six agents: 0.1 IJ-M TTX, 20 IJ-M APB, 1 mM APV, 1 mM amiloride, 10 mM Mg 2 +, 10 mM Li +. The vertical bars represent 50 IJ-V.
CONnlOLS
privation, as shown in the upper part of Fig. 2 and the right side of Fig. 3 . After V2 h of deprivation, recovery was prompt and complete. After 1 h, re covery was slower and incomplete, asymptoting in 3 h at �50% of the control value. When the depri vation was extended to 2 or 3 h, there was little or no recovery.
Effects of the protective agents
When administered with O 2 and glucose at con trol levels, the combination of six agents eliminated all of the light-evoked responses (not shown). The nerve action potentials and the b wave of the ERG disappeared within 1 min; but the PIn of the ERG was more resistant to the drugs, falling to V4 of its control amplitude in � 7 min and disappearing com pletely in �25 min. The drug combination also caused a reduction in glucose consumption. In the J Cereb Blood Flow Metab, Vol. 15, No. 3, 1995 absence of the drugs, retinas exposed to the isch emic conditions removed glucose from the medium at the rate of 78 ± 12 (SD; n = 4) nmol min -1 . With the drugs present, the rate of glucose consumption was reduced by 80% to 15 ± 3 (n = 2) nmol min -1 . Because the retinas weighed � 11 mg dry (63 mg wet), this represented � 7.1 !-Lmol g -1 min -1 with out drugs and 1.4 !-Lmol g -1 min -1 with drugs.
In the experiments in which the six function blocking agents were present during the O 2 and glu cose deprivation, the optic nerve responses recov ered fully after return to control conditions, even after deprivations of 3 h (traces in lower half of Figs. 2 and 4) . Of the four retinas subjected to 2 or 3 h of energy deprivation with protection, none showed <98% recovery of function; whereas, of the six retinas subjected to 2 or 3 h of deprivation with out protection, none showed > l3% recovery. The Hours of Recovery   FIG. 3. The curve on the left shows the loss of the light-evoked action potentials of the optic nerve when O 2 was reduced from 95 to 15% and glucose from 6 to 1 mM. The curves on the right show rates of recovery when the retinas were returned to control conditions following deprivations lasting '/2 (e), 1 (0), 2 (A) or 3 h (\7). The compound action potentials in response to ON and OFF of the light (Fig. 2) recorded during and following the deprivation were expressed as percentages of the respective control responses recorded before deprivation. The values thus obtained for both ON and OFF responses of a retina were then averaged to obtain an estimate of the retina's function at that time point. None of the retinas from which these data were obtained were "protected" during the ischemic insult. The exponential curve on the left was computer-fitted to 15 measurements on seven retinas. The data on the right are averages ± SO for two retinas ('/2 and 1 h) or 3 retinas (2 and 3 h).
difference was significant (p < 0. 01) as assessed by a 2-sided Wilcoxon test. As shown in Figs. 3 and 4 , the recovery of the protected retinas after 3 h of ischemic challenge (119 ± 26% SD; n = 3) appeared to be better than the recovery of the unprotected retinas after only 1 h of deprivation (46 ± 6%; n = 2), though the numbers are inadequate for statistical analysis.
Changes in the PIlI of the in vitro ERG In retinas isolated without the pigment epithelium (as in our experiments), the principal response to a bright light recorded with transretinal electrodes is a sustained vitreous-negative deflection (the PIlI), caused by the interruption of the "dark-current" of the photoreceptors. The PIlI averaged 397 ± 125 f.L V (SD; n = 14) under control conditions. It was less constant than the nerve action potentials, but more resistant to the reduction in O 2 and glucose. After 2 or 3 h of deprivation without protective agents the PIlI remained at 88 ± 39% (SD; n = 7) of its control value. There was no significant change in the PIli during the 4 h of recovery and no significant effect of the protective agents on the amplitude of the PIli at the end of the recovery period.
DISCUSSION
We sought to assess the protective effect of the drugs under conditions that simulated a stroke, so the retinas were subjected to a reduction in O 2 and glucose comparable to the reduction in regional blood flow during a stroke (see Methods). The re sponse of the retinas appears to have been similar to the response to a stroke. There was a marked dif ference between the time required for loss of func tion (which was measured in seconds) and the time required for the appearance of irreversible damage (more than 1/2 h). The time at which the irreversible damage became maximum (i.e., the "window of op portunity" for possible intervention) was �2 h, or similar to that reported for strokes in primates (Morawetz et aI., 1979) and rats (Kaplan et aI., 199 1; Buchan et aI., 1992; Memezawa et aI., 1992) . See also review by Ginsberg (1994) . Fortunately for purposes of the study the most specialized cells in the retina, the photoreceptors, were relatively re sistant (as indicated by the retention of the PIlI), so the recovery of the optic nerve response probably depended on recovery of the neurons of the inner retina which are quite representative of neurons elsewhere in CNS. As indicated above, the recov ery of both ON and OFF responses must reflect the recovery of two, quite separate, multineuronal cir cuits.
It should be recognized that our ischemic chal lenge differed in an important respect from a stroke in vivo. The energy-deprived retinas continued to be bathed in a large volume of medium, so there was little opportunity for the accumulation of toxic by-products of ischemia. It seems unlikely that this led to a false-positive result because there would probably have been a greater accumulation of toxic by-products in the retinas whose functional activity had not been reduced by the drugs.
There was no evidence of reperfusion injury in these experiments. The recovery of the control ret inas (when it occurred) was progressive with no in dication of a delayed reversal (Fig. 3, right) , and the protected retinas showed full recovery even though the protective agents were absent during the period of resupply.
The six agents to which the retinas were exposed during the experimental ischemia had been selected on the basis of previous studies (see Methods) for their capacity to block function and reduce energy requirements, and we believe that these actions were responsible for the protection they provided. We recognize this is a somewhat unconventional J Cereb Blood Flow Me/ab, Vol. 15, No.3, 1995 interpretation. Four of the agents have been previ· ously reported to improve recovery following an ischemia-like challenge, and their beneficial effects were usually attributed, not to a reduction in energy requirements, but to protective effects against isch emia-induced changes: tetrodotoxin (Stys et aI., 1992) ; APV (e.g., Monyer et aI., 1989; Hartley and Choi, 1989; Tombaugh and Sapolsky, 1990) ; amiloride (Manev et aI., 1990; Weiss et aI., 1990) ; Mg 2 + (Vacanti and Ames, 1984; Izumi et aI., 1991) .
The distinction between prevention and protection is important. If ischemia can be prevented by rees tablishing the balance between energy supply and demand, an otherwise damaging level of hypoper fusion could presumably be sustained indefinitely. Whereas, treating the adverse effects of energy de privation cannot be expected to be all-inclusive, and some of them (e.g., impaired synthesis of new protein) will probably eventually lead to loss of vi ability. The protection provided by the agents used in our experiments probably has much in common with the protection provided by hypothermia, which is known to reduce physiologic activity, energy re quirements, and damage from ischemic insults (Busto et aI., 1987; Lust et aI., 1989; Buchan and Pulsinelli, 1990; Xue et aI., 1992; Taylor and Weber, 1993) . A reduction in temperature would appear to be an important addition to any pharmacologic reg imen designed to prevent energy imbalance in tissue that is hypoperfused.
These were initial experiments. The relative ef fectiveness of the six agents tested remains un known. Many other agents of potential interest are already available, and ongoing research on selective blockers of receptors and ion channels will un doubtedly identify new ones. A systematic search for combinations of agents that reversibly interrupt processes that are not essential to cell viability may be of value for protecting other tissues that perform energy-demanding functions (e.g., heart, kidney, liver), and may even find application in preserving organs for transplant.
